MAPK1 and RASopathy: Lastly, WES sequencing in a group of patients showing neurodevelopmental alterations within the RASopathy spectrum coupled to functional validation in nematodes has more recently established the pathogenicity of de novo mutations affecting MAPK1 (ERK2) directly and possibly their ability to interact with regulators and effectors (Motta et al., 2020).